Effects of GABAB receptor agonists on cocaine hyperlocomotor and sensitizing effects in rats

Pharmacological Reports

Volumn 61, Issue 6, 2009, Pages 1042-1049

  Frankowska, Małgorzata ^a   Nowak, Ewa ^a   Filip, Małgorzata ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Baclofen; Behavioral sensitization; Cocaine; Locomotor activity; SKF 97541

Indexed keywords

3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; COCAINE; 3-AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ORGANOPHOSPHORUS COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; HYPERACTIVITY; MALE; NONHUMAN; RAT; SENSITIZATION; WISTAR RAT; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; HYPERKINESIA; METABOLISM; MOTOR ACTIVITY;

ANIMALS; BACLOFEN; BEHAVIOR, ANIMAL; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; HYPERKINESIS; MALE; MOTOR ACTIVITY; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR; RECEPTORS, GABA-B;

EID: 76049089495     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70166-5     Document Type: Article

References (46)

1. Bartoletti M, Gubellini C, Ricci F, Gaiardi M: Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav Pharmacol, 2005, 16, 553-558.
2. B agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behav Pharmacol, 2004, 15, 397-401.
3. B agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology, 2007, 192, 79-85.
4. B receptors. Physiol Rev, 2004, 84, 835-867.
5. BR1 receptor mRNA and binding sites in the rat brain. J Comp Neurol, 1999, 412, 1-16.
6. Bowery NG: GABA receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci, 1989, 10, 401-407.
7. B receptor site distribution in the rat central nervous system. Neuroscience, 1987, 20, 365-383.
8. B agonists in the treatment of psychostimulant addiction. Alcohol Alcohol, 2002, 37, 478-484.
9. Brebner K, Froestl W, Roberts DC: The GABA antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat. Psychopharmacology, 2002, 160, 49-55.
10. Brebner K, Phelan R, Roberts DC: Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav, 2000, 66, 857-862.
11. Campbell UC, Lac ST, Carroll ME: Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology, 1999, 143, 209-214.
12. Di Chiara G: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend, 1995, 38, 95-137.
13. Di Ciano P, Everitt BJ: The GABA receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology, 2003, 28, 510-518.
14. B receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn-Schmiedeberg's Arch Pharmacol, 2002, 365, 173-180.
15. Fadda P, Scherma M, Fresu A, Collu M, Fratta W: Baclofen antagonizes nicotine-, cocaine-, and morphineinduced dopamine release in the nucleus accumbens of rat. Synapse, 2003, 50, 1-6.
16. B receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol, 2007, 571, 166-173.
17. B receptors in drug addiction. Pharmacol Rep, 2008, 60, 755-770.
18. Filip M, Frankowska M, Gołda A, Zaniewska M, Vetulani J, Przegaliński E: Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. Eur J Pharmacol, 2006, 541, 163-170.
19. Filip M, Frankowska M, Przegaliński E: Effects of GABA receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol, 2007, 574, 148-157.
20. Filip M, Siwanowicz J: Implication of the nucleus accumbens shell, but not core, in the acute and sensitizing effects of cocaine in rats. Pol J Pharmacol, 2001, 53, 459-466.
21. Frankowska M, Wydra K, Faron-Górecka A, Zaniewska M, Kúsmider M, Dziedzicka-Wasylewska M, Filip M: Alterations in γ-aminobutyric acid receptor binding in the rat brain after reinstatement of cocaine-seeking behavior. Pharmacol Rep, 2008, 60, 834-843.
22. Froestl W, Mickel SJ, Hall RG, von Sprecher G, Strub D, Baumann PA, Brugger F et al.: Phosphinic acid analogues of GABA. 1. New potent and selective GABA agonists. J Med Chem, 1995, 38, 3297-3312.
23. Gardner EL, Schiffer WK, Horan BA, Highfield D, Dewey SL, Brodie JD, Ashby CR Jr: Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse, 2002, 46, 240-250.
24. B receptors is altered after repeated amphetamine treatment. Neuroscience, 2002, 109, 585-595.
25. Hotsenpiller G, Wolf ME: Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens. Neuroscience, 2003, 118, 123-134.
26. Itzhak Y, Martin JL: Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology, 2000, 151, 226-233.
27. Kalivas PW, Duffy P, Eberhardt H: Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther, 1990, 253, 858-866.
28. Kalivas PW, Nakamura M: Neural systems for behavioral activation and reward. Curr Opin Neurobiol, 1999, 9, 223-227.
29. Kalivas PW, Pierce RC, Cornish J, Sorg BA: A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol, 1998, 12, 49-53.
30. Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev, 1991, 16, 223-244.
31. B receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiateinduced motor sensitization. J Pharmacol Exp Ther, 2004, 308, 667-678.
32. B receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology, 2007, 32, 388-398.
33. Liang F, Hatanaka Y, Saito H, Yamamori T, Hashikawa T: Differential expression of γ-aminobutyric acid type B receptor-1a and -1b mRNA variants in GABA and non-GABAergic neurons of the rat brain. J Comp Neurol, 2000, 416, 475-495.
34. Phillis BD, Ong J, White JM, Bonnielle C: Modification of d-amphetamine-induced responses by baclofen in rats. Psychopharmacology, 2001, 153, 277-284.
35. Roberts DC, Brebner K: GABAmodulation of cocaine self-administration. Ann NY Acad Sci, 2000, 909, 145-158.
36. Robinson TE, Berridge KC: Addiction. Ann Rev Psychol, 2003, 54, 25-53.
37. Robinson TE, Berridge KC: Incentive-sensitization and addiction. Addiction, 2001, 96, 103-114.
38. B agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol, 1998, 9, 195-206.
39. Steketee JD, Kalivas PW: Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther, 1991, 259, 916-924.
40. Stewart J, Badiani A: Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol, 1993, 4, 289-312.
41. Vanderschuren LJ, Kalivas PW: Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology, 2000, 151, 99-120.
42. Westerink BH, Enrico P, Feimann J, De Vries JB: The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther, 1998, 285, 143-154.
43. Westerink BH, Kwint HF, de Vries JB: Eating-induced dopamine release from mesolimbic neurons is mediated by NMDA receptors in the ventral tegmental area: a dual-probe microdialysis study. J Neurochem, 1997, 69, 662-668.
44. B receptors in midbrain monoamine containing neurons in the rat. Brain Res Bull, 2001, 56, 1-5.
45. Woo SH, Kim HS, Yun JS, Lee MK, Oh KW, Seong YH, Oh SK, Jang CG: Inhibition of baclofen on morphineinduced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity. Pharmacol Res, 2001, 43, 335-340.
46. Zaniewska M, McCreary AC, Sezer G, Przegaliński E, Filip M: Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol Rep, 2008, 60, 645-654.